Sleep and Type 1 Diabetes
SLEEPT1D
Sleep and Glycemic Control in Type 1 Diabetic Children
1 other identifier
interventional
70
1 country
1
Brief Summary
The primary goal of the study is to determine whether insufficient sleep is associated with poor glycemic control in type 1 diabetic children. Secondary goals aim to determine whether salivary amylase could be an easily accessible and non-invasive biomarker of sleep loss and somnolence, and whether insufficient sleep is linked to body composition. Sleep characteristics, glycemic control, salivary amylase and body composition will be assessed 3 times, at 3-4 months intervals, in 82 type 1 diabetic children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2015
CompletedFirst Submitted
Initial submission to the registry
July 3, 2015
CompletedFirst Posted
Study publicly available on registry
July 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedOctober 5, 2020
October 1, 2020
7.4 years
July 3, 2015
October 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between HbA1c and sleep characteristics
Month 3, Month 6 and Month 9
Secondary Outcomes (3)
Glucose levels
Month 3, Month 6 and Month 9
Daily salivary amylase variation (Enzyme Activity)
Month 3, Month 6 and Month 9
Body composition (BMI fat and lean mass percentage)
Month 3, Month 6 and Month 9
Study Arms (1)
Sleep and glucose assessement.
EXPERIMENTALInterventions
Sleep characteristics, glycemic control, salivary amylase and body composition will be assessed 3 times, at 3-4 months intervals
Eligibility Criteria
You may qualify if:
- \- Female and male type 1 diabetic children and adolescents who are followed at the Woman, Mother and Child's Hospital (Hôpital Femme Mère Enfant : HFME) of Bron, France.
You may not qualify if:
- Refusal of consent of the parents or the child or the adolescent
- Pregnancy
- Concomitant pathology that severly impacts sleep
- Implanted electrical stimulation device
- Diagnosis of type 1 diabetes \<1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon
Lyon, 69000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2015
First Posted
July 10, 2015
Study Start
June 28, 2015
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
October 5, 2020
Record last verified: 2020-10